**BU – Transcatheter Mitral & Tricuspid Therapies**

Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s unmet clinical needs. It’s our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey.

Patients are at the heart of everything we do. As part of the TMTT Medical Affairs team, you will elevate Edwards' scientific leadership and accelerate impact in transcatheter mitral and tricuspid therapies through evi-dence-based exchange, trusted external relationships, and cross-functional partnership across France.
This **permanent France-based role will lead Medical Affairs for the TMTT portfolio, including PASCAL, EVOQUE, and SAPIEN M3** , with focus on evidence generation, scientific communication, KOL e...